Soluble CD40 ligand derived from serum is not correlated with early MS.

Zahednasab, Hamid; Siroos, Bahaadin; Balood, Mohammad; Aleagha, Mohammad Sajad Emami; Harirchian, Mohammad Hossein

Zahednasab, Hamid; Siroos, Bahaadin; Balood, Mohammad; Aleagha, Mohammad Sajad Emami; Harirchian, Mohammad Hossein.

Affiliation

Zahednasab H; Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.
Siroos B; Iranian Centre of Neurological Research, Department of Neurology Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Balood M; Department of Clinical Biochemistry, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Aleagha MSE; Department of Clinical Biochemistry, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Harirchian MH; Iranian Centre of Neurological Research, Department of Neurology Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: harirchm@tums.ac.ir.

Mult Scler Relat Disord ; 14: 29-31, 2017 May.

Article in En | MEDLINE | ID: mdl-28619427

Subject(s)

CD40 Ligand/blood; Multiple Sclerosis/blood; Adult; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Multiple Sclerosis/physiopathology; Severity of Illness Index; Young Adult

Key words

ELISA; Multiple sclerosis; Serum; sCD154

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CD40 Ligand / Multiple Sclerosis Type of study: Observational_studies Limits: Adult / Female / Humans / Male Language: En Journal: Mult Scler Relat Disord Year: 2017 Document type: Article Affiliation country: Iran Country of publication: Netherlands

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google